Literature DB >> 20028806

Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.

Gayle M Boxx1, Thomas R Kozel, Casey T Nishiya, Mason X Zhang.   

Abstract

The complement system is important for host resistance to hematogenously disseminated candidiasis. However, modulation of complement activation by cell wall components of Candida albicans has not been characterized. Although intact yeast display mannan on the surface, glucan, typically located in the interior, becomes exposed during C. albicans infection. We show here the distinct effects of mannan and glucan on complement activation and opsonophagocytosis. Previous studies showed that intact cells are resistant to initiation of complement activation through the alternative pathway, and antimannan antibody reverses this resistance via an Fc-independent mechanism. The present study shows that this mannan-dependent resistance can be overcome by periodate-borohydride conversion of mannose polysaccharides to polyalcohols; cells treated with periodate-borohydride initiate the alternative pathway without the need for antibody. These observations identify an inhibitory role for intact mannan in complement activation. Next, removal of the surface-displayed mannan by acid treatment of periodate-borohydride cells exposes glucan. Glucan-displaying cells or purified beta-glucan initiate the alternative pathway when incubated with the purified proteins of the alternative pathway alone, suggesting that C. albicans glucan is a natural activator of the alternative pathway. Finally, ingestion of mannan-displaying cells by human neutrophils requires anti-mannan antibody, whereas ingestion of glucan-displaying cells requires complement. These results demonstrate a contrasting requirement of natural antibody and complement for opsonophagocytosis of C. albicans cells displaying mannan or glucan. Thus, differential surface expression of mannan and glucan may influence recognition of C. albicans by the complement system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20028806      PMCID: PMC2825936          DOI: 10.1128/IAI.00744-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

Review 1.  Complement evasion of pathogens: common strategies are shared by diverse organisms.

Authors:  Peter F Zipfel; Reinhard Würzner; Christine Skerka
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

Review 2.  Defining criteria for anti-mannan antibodies to protect against candidiasis.

Authors:  J E Cutler
Journal:  Curr Mol Med       Date:  2005-06       Impact factor: 2.222

3.  Candida albicans cell wall comprises a branched beta-D-(1-->6)-glucan with beta-D-(1-->3)-side chains.

Authors:  Egidio Iorio; Antonella Torosantucci; Carla Bromuro; Paola Chiani; Amalia Ferretti; Massimo Giannini; Antonio Cassone; Franca Podo
Journal:  Carbohydr Res       Date:  2008-02-29       Impact factor: 2.104

4.  Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans.

Authors:  Kathrin Held; Steffen Thiel; Michael Loos; Franz Petry
Journal:  Mol Immunol       Date:  2008-07-30       Impact factor: 4.407

5.  Anti-beta-glucan antibodies in healthy human subjects.

Authors:  P Chiani; C Bromuro; A Cassone; A Torosantucci
Journal:  Vaccine       Date:  2008-11-27       Impact factor: 3.641

6.  Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.

Authors:  Gayle M Boxx; Casey T Nishiya; Thomas R Kozel; Mason X Zhang
Journal:  Mol Immunol       Date:  2008-11-26       Impact factor: 4.407

7.  A novel glyco-conjugate vaccine against fungal pathogens.

Authors:  Antonella Torosantucci; Carla Bromuro; Paola Chiani; Flavia De Bernardis; Francesco Berti; Chiara Galli; Francesco Norelli; Cinzia Bellucci; Luciano Polonelli; Paolo Costantino; Rino Rappuoli; Antonio Cassone
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

8.  Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.

Authors:  Robert T Wheeler; Diana Kombe; Sudeep D Agarwala; Gerald R Fink
Journal:  PLoS Pathog       Date:  2008-12-05       Impact factor: 6.823

9.  Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.

Authors:  Antonella Torosantucci; Paola Chiani; Carla Bromuro; Flavia De Bernardis; Angelina S Palma; Yan Liu; Giuseppina Mignogna; Bruno Maras; Marisa Colone; Annarita Stringaro; Silvia Zamboni; Ten Feizi; Antonio Cassone
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

10.  A drug-sensitive genetic network masks fungi from the immune system.

Authors:  Robert T Wheeler; Gerald R Fink
Journal:  PLoS Pathog       Date:  2006-04-28       Impact factor: 6.823

View more
  12 in total

1.  Impaired phagocytosis directs human monocyte activation in response to fungal derived β-glucan particles.

Authors:  Giorgio Camilli; Elif Eren; David L Williams; Vishukumar Aimanianda; Etienne Meunier; Jessica Quintin
Journal:  Eur J Immunol       Date:  2018-02-05       Impact factor: 5.532

2.  Integrin-based diffusion barrier separates membrane domains enabling the formation of microbiostatic frustrated phagosomes.

Authors:  Michelle E Maxson; Xenia Naj; Teresa R O'Meara; Jonathan D Plumb; Leah E Cowen; Sergio Grinstein
Journal:  Elife       Date:  2018-03-19       Impact factor: 8.140

3.  Next-generation computational genetic analysis: multiple complement alleles control survival after Candida albicans infection.

Authors:  Gary Peltz; Aimee K Zaas; Ming Zheng; Norma V Solis; Mason X Zhang; Hong-Hsing Liu; Yajing Hu; Gayle M Boxx; Quynh T Phan; David Dill; Scott G Filler
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

4.  Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.

Authors:  Casey T Nishiya; Gayle M Boxx; Kerry Robison; Carol Itatani; Thomas R Kozel; Mason X Zhang
Journal:  Infect Immun       Date:  2015-11-16       Impact factor: 3.441

5.  Responses of Candida albicans to the human antimicrobial peptide LL-37.

Authors:  Pei-Wen Tsai; Yin-Lien Cheng; Wen-Ping Hsieh; Chung-Yu Lan
Journal:  J Microbiol       Date:  2014-05-30       Impact factor: 3.422

6.  Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration.

Authors:  Eva Pericolini; Stefano Perito; Anna Castagnoli; Elena Gabrielli; Antonella Mencacci; Elisabetta Blasi; Anna Vecchiarelli; Robert T Wheeler
Journal:  PLoS One       Date:  2018-07-31       Impact factor: 3.240

7.  Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent.

Authors:  Nandita Bose; Anissa S H Chan; Faimola Guerrero; Carolyn M Maristany; Xiaohong Qiu; Richard M Walsh; Kathleen E Ertelt; Adria Bykowski Jonas; Keith B Gorden; Christine M Dudney; Lindsay R Wurst; Michael E Danielson; Natalie Elmasry; Andrew S Magee; Myra L Patchen; John P Vasilakos
Journal:  Front Immunol       Date:  2013-08-12       Impact factor: 7.561

Review 8.  Immune Recognition of Fungal Polysaccharides.

Authors:  Brendan D Snarr; Salman T Qureshi; Donald C Sheppard
Journal:  J Fungi (Basel)       Date:  2017-08-28

Review 9.  Candida and Complement: New Aspects in an Old Battle.

Authors:  Verena Harpf; Günter Rambach; Reinhard Würzner; Cornelia Lass-Flörl; Cornelia Speth
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

10.  Orally delivered β-glucans aggravate dextran sulfate sodium (DSS)-induced intestinal inflammation.

Authors:  Sigrid E M Heinsbroek; David L Williams; Olaf Welting; Sybren L Meijer; Siamon Gordon; Wouter J de Jonge
Journal:  Nutr Res       Date:  2015-10-20       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.